Essential roles of B cell subsets in the progression of MASLD and HCC

Background & Aims: Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related death. Metabolic dysfunction-associated steatotic liver disease (MASLD) is a significant cause of HCC. Current treatment options for HCC are very limited. Recent evidence highlights B cells as key driv...

Descripció completa

Dades bibliogràfiques

Autors principals:	Nataliia Petriv, Huizhen Suo, Inga Hochnadel, Kai Timrott, Nina Bondarenko, Lavinia Neubert, Elena Reinhard, Nils Jedicke, Patrick Kaufhold, Carlos Alberto Guzmán, Ralf Lichtinghagen, Michael P. Manns, Heike Bantel, Tetyana Yevsa
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2024-12-01
Col·lecció:	JHEP Reports
Matèries:	Metabolic dysfunction-associated steatotic liver disease Non-alcoholic fatty liver disease Hepatocellular carcinoma B cells B regulatory cells Memory B cells
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2589555924001939
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!